| GEMCAD-REVEAL STUDY - Circulating Tumor DNA as a Predictor of Relapse in Patients With Locally Advanced Rectal Cancer. (NCT05674422) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2023-05-26 |
| Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS) (NCT05661188) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2023-02-14 |
| Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC). (NCT05201612) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2022-07-07 |
| Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease (NCT04595266) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2021-06-29 |
| Durvalumab (MEDI4736) Plus Total Neoadjuvant Therapy (TNT) in Locally Advanced Rectal Cancer (NCT04293419) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2019-12-18 |
| Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal (NCT03751176) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2018-11-08 |
| Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients (NCT03152565) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2018-03-12 |
| FOLFIRI + Panitumumab First-line Treatment in Elderly Patients With Unresectable Metastatic Colorectal Cancer, RAS/BRAF Wild-type and Good Performance Status (NCT03142516) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2017-10-31 |
| Induction Therapy With Panitumumab + mFOLFOX-6 in Rectal Cancer and Quadruple Wild-type Mutation Before Surgery (NCT03000374) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2017-05-30 |
| Induction FOLFOX With or Without Aflibercept Followed by Chemoradiation in High Risk Locally Advanced Rectal Cancer (NCT02340949) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2015-01-01 |
| Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer (NCT02254941) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2014-08-01 |
| Correlation Between RECIST, Morphologic Response by CT- Histopathologic Response in Hepatic Metastasis Secondary to Colorectal Cancer (NCT01493713) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2011-11-16 |
| Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer (NCT01389440) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2011-05-01 |
| Study Evaluating Biomarkers in Patients With Colorectal Cancer and Native KRAS Treated With Chemotherapy + Cetuximab (NCT01276379) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2011-01-01 |
| Study Assessing Potential Predictive Tumor Markers in Metastatic Colorectal Cancer (NCT01288339) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2010-11-08 |
| Vectibix for the Treatment of Anal Cancer (NCT01285778) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2010-10-01 |
| Efficacy/Safety Study of Bevacizumab,Capecitabine,Oxaliplatin to Metastatic Colorectal Adenocarcinoma Elderly Patients. (NCT01067053) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2009-11-01 |
| Study of Neoadjuvant CT With Selective Radiotherapy in Patients With Intermediate-Risk Cancer Rectum (NCT00909987) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2009-03-01 |
| Study of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based Treatment (NCT01262482) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2008-10-01 |
| Phase I-II to Evaluate Efficacy/Safety of Sorafenib+Gemcitabine+Radiotherapy in Locally Advanced Pancreatic Carcinoma (NCT00789763) | Grupo Espanol Multidisciplinario del Cancer Digestivo | 2007-12-01 |